ACE and myocardial infarction: Clinical research has also demonstrated that combining plasmapheresis with ARBs reduces the risk of acute rejection in transplant patients (55), and recent findings indicate that ARBs are linked to lower overall mortality and fewer heart failure hospitalizations than ACE inhibitors in myocardial infarction patients (56).